FDA’s Sedation Product Workshop Will Be A Solo Affair
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency had previously solicited proposals that an outside body or bodies evaluate the issues and sponsor a conference, but has now decided to do the work for the May 3 event in-house, albeit with outside input.